Skip to main content
AI/ML Innovations Inc. logo

AI/ML Innovations Inc. — Investor Relations & Filings

Ticker · AIML ISIN · CA00143Y1034 LEI · 5493004TJHMBXORVTD12 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 532 across all filing types
Latest filing 2022-02-07 Regulatory Filings
Country CA Canada
Listing CSE AIML

About AI/ML Innovations Inc.

https://aiml-innovations.com/

AI/ML Innovations Inc. is a digital healthcare technology company specializing in the application of Artificial Intelligence (AI) and Machine Learning (ML) neural networks to revolutionize non-invasive medicine and biometric intelligence. The company develops proprietary platforms that leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights, supporting proactive and personalized care. Its flagship technology, MaxYield, is a cutting-edge Signal Processing Neural Network designed to extract high-fidelity signals from noisy recordings, initially focused on enhancing the clarity and accuracy of ECG data by delivering clean, "Neuralized" waveforms and precise PQRST data walls. Through its subsidiaries, the company provides AI-powered solutions like CardioYield™ for Holter analysis, aiming to integrate seamlessly with existing clinical and wellness workflows.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release announcing that AI/ML Innovations Inc.'s subsidiary Tech2Heal has been selected for a prestigious health tech campus. It contains no financial statements, no detailed financial performance data, no regulatory filings, no voting results, no management or board changes, no earnings data, no capital or financing updates, and no legal proceedings. It is a corporate announcement about a business development and partnership opportunity. The document length is 6140 characters, which is sufficient for a news release but does not contain the characteristics of any financial or regulatory report. Therefore, the document is best classified as a Regulatory Filing (RNS), which is the fallback category for general regulatory announcements and miscellaneous filings that do not fit other categories.
2022-02-07 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed instructions and fields related to filing reports of exempt distributions in Canadian jurisdictions. It includes regulatory references to Canadian securities laws and filing requirements for issuers and underwriters. The content is a regulatory form used for reporting exempt distributions of securities, not a financial report, earnings release, or management discussion. It is a regulatory filing form used to comply with securities regulations, thus it fits best under the category of Regulatory Filings (RNS). The document length is substantial and contains the form itself, not just an announcement or certification, but it is not a financial report or other specific filing type.
2022-02-05 English
News release - English.pdf
Regulatory Filings
2022-02-01 English
News release - English.pdf
Regulatory Filings
2022-01-27 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CEO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended October 31, 2021. It is a certification letter rather than the interim report itself. The document length is short (3035 characters) and it primarily contains officer certification statements without substantive financial data or analysis. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) itself.
2021-12-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification letter by the CFO of AI/ML Innovations Inc. regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended October 31, 2021. It is a Form 52-109FV2, a certification of interim filings for a venture issuer. The document does not contain actual financial data or substantive financial analysis but is an officer certification. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3037 characters), and it is clearly a certification rather than the report or announcement of a report.
2021-12-30 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.